This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Bloomsbury Genetic Therapies


We are a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases based on clinically proven gene therapy technologies. Our vision is to deliver on the promise of fast and capital-efficient development of gene therapies in rare diseases by leveraging de-risked platforms, such as capsids and routes of administration, and optimised, proprietary vector constructs.

We're bringing you

  • Startup spotlight pitch competition